The Global Wearable Injectors Market is likely to derive growth from the increasing prevalence of chronic diseases. According to a report by Fortune Business Insights, titled “Wearable Injectors Market Size, Share and Global Trend by Type (On-body Wearable Injectors, Off-body Wearable Injectors), By Application (Oncology, Neurology, Diabetes, Cardiology, Others), By End User (Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings, Others) and Geography Forecast till 2026,” the market will benefit from the exceptional properties of wearable injectors.
Some of the leading companies that are operating in the global wearable injectors market are:
- Consort Medical plc
- Sensile Medical AG
- Enable Injections
- Ypsomed AG
- Valeritas, Inc.
- United Therapeutics Corporation
- Amgen Inc
Wearable injectors are used to inject drugs and other fluids into the body in cases where larger volumes of drugs are required. The properties of wearable injectors have led to a huge adoption across the world. Exceptional product applications have offered a wider scope for the companies operating in the wearable injectors market. Fortune Business Insights has predicted that the variations in products, combined with the high demand for these products will constitute an increase in the global wearable injectors market value in the coming years. The accuracy in drug dosing and highly precise drug delivery systems will contribute to an increase in the global wearable injectors market size in the forthcoming years.
The report provides quantitative as well as qualitative analysis of the global wearable injectors market. The data provided in this report is gathered through some extensive research analysis methods. The report provides insights into the variations of wearable injectors, regions that have seen the most product adoption and enlists the leading product type. Additionally, the report provides detailed analysis of the leading companies that are operating in the global wearable injectors market and forecasts companies that are likely to emerge dominant for the period of 2019-2026.
The report segments the global wearable injectors market based on factors such as type, application, end users, and regional demographics. Fortune Business Insights has predicted that North America is likely to dominate the global market due to the increasing prevalence of chronic diseases and high adoption of advanced healthcare technologies. Additionally, growing emphasis on reducing treatment costs and patient convenience. Having said that, Europe offers a high growth potential due to the increasing adoption of self-administration.
Key Segments of Wearable Injectors Market:
- On-Body Wearable Injectors
- Off-Body Wearable Injectors
By End User
- Ambulatory Surgery Centers
- Home Care Settings
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Increasing Product Launches Will Enable Market Growth
Fortune Business Insights encompasses several factors that have contributed to the global wearable injectors market growth. Among all factors, Fortune Business Insights labels increasing number of product launches as one of the primary factors that have helped companies generate substantial wearable injectors market revenue. In 2018, BD announced the launch of a new product capable of delivering large volume of drugs. The ‘Libertas’ possessed the ability to deliver high viscosity drugs subcutaneously. Due to exceptional properties, Fortune Business Insights has predicted that the device will help the company generate significant wearable injectors market revenue. The report includes product launches, similar to BD’s latest device and gauges the impact of these products on the global wearable injectors market.
Increasing Prevalence of Chronic Disease to Fuel Demand
The high prevalence of chronic diseases will offer a huge growth potential for the companies operating in the global wearable injectors market. According to the World Health Organization (WHO), chronic diseases accounted for almost 60% of all diseases in the world and this number is likely to rise to around 73% by 2020. The treatment of chronic diseases through wearable injectors is seen to possess high operational efficacies, which in turn is likely to affect the global wearable injectors market in the forthcoming years.
More Trending Topics from Fortune Business Insights:
Phoropters Market Worldwide Growth, Trends, Share, Industry Analysis, Regional Overview, Forecast till 2026
Drug Screening Market Top Key Vendors, Industry Growth, Regional Analysis, Global Trends, Share, Size Forecast till 2026
Spinal Devices Market Latest Innovative, Worldwide Opportunities by Top Players | Medtronic, Stryker, Alphatec Spine, Inc, RTI Surgical Holdings, Inc and Others Forecast till 2026